Cardlytics, Inc. Files Material Definitive Agreement
Ticker: CDLX · Form: 8-K · Filed: Oct 3, 2024 · CIK: 1666071
| Field | Detail |
|---|---|
| Company | Cardlytics, Inc. (CDLX) |
| Form Type | 8-K |
| Filed Date | Oct 3, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, sec-filing
TL;DR
Cardlytics just signed a big deal, details in new 8-K.
AI Summary
On September 30, 2024, Cardlytics, Inc. entered into a Material Definitive Agreement, the specifics of which are detailed in this 8-K filing. The agreement was filed with the SEC on October 3, 2024, and pertains to the company's operations as of September 30, 2024.
Why It Matters
This filing indicates a significant new agreement for Cardlytics, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Material Definitive Agreements can introduce new risks or opportunities that may affect the company's financial health and stock performance.
Key Numbers
- 001-38386 — SEC File Number (Identifies the company's filings with the SEC.)
- 26-3039436 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Cardlytics, Inc. (company) — Registrant
- September 30, 2024 (date) — Date of earliest event reported
- October 3, 2024 (date) — Filing date
- 675 Ponce de Leon Avenue NE, Suite 6000 (address) — Principal executive offices
FAQ
What type of Material Definitive Agreement did Cardlytics, Inc. enter into?
The filing indicates the entry into a Material Definitive Agreement, but the specific nature of the agreement is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated September 30, 2024.
On what date was this 8-K form filed with the SEC?
This 8-K form was filed on October 3, 2024.
What is the principal executive office address for Cardlytics, Inc.?
The principal executive offices are located at 675 Ponce de Leon Avenue NE, Suite 6000, Atlanta, Georgia 30308.
What is Cardlytics, Inc.'s SEC file number?
Cardlytics, Inc.'s SEC file number is 001-38386.
Filing Stats: 529 words · 2 min read · ~2 pages · Grade level 13.8 · Accepted 2024-10-03 16:03:44
Filing Documents
- cdlx-20240930.htm (8-K) — 27KB
- cdlx-20240930_g1.jpg (GRAPHIC) — 26KB
- 0001666071-24-000152.txt ( ) — 238KB
- cdlx-20240930.xsd (EX-101.SCH) — 3KB
- cdlx-20240930_def.xml (EX-101.DEF) — 14KB
- cdlx-20240930_lab.xml (EX-101.LAB) — 25KB
- cdlx-20240930_pre.xml (EX-101.PRE) — 15KB
- cdlx-20240930_htm.xml (XML) — 3KB
01 Entry into a Material Definitive Agreement
ITEM 1.01 Entry into a Material Definitive Agreement On September 30, 2024, Cardlytics, Inc. (the "Company") entered into an amended and restated loan and security agreement (the "Agreement") by and among the Company, certain subsidiaries of the Company named therein and Banc of California, N.A ("Lender"), formerly known as Pacific Western Bank. The Agreement amends and restates the original Loan and Security Agreement, dated as of May 21, 2018, by and between Company and Lender, as subsequently amended (the "Existing Agreement"). The Agreement consolidates the Existing Agreement and all subsequent amendments thereto into a single document. Except for immaterial changes, the terms of the Agreement are consistent with the terms of the Existing Agreement, as described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. The foregoing description of the Agreement is not complete and is qualified in its entirety by reference to the Agreement, which the Company intends to file as an exhibit to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Cardlytics, Inc. Date: October 3, 2024 By: /s/ Alexis DeSieno Alexis DeSieno Chief Financial Officer (Principal Financial and Accounting Officer)